Open AccessComparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
Author(s) -
Jan Roczniak,
Justyna Bączalska,
Gabriela Kanclerz,
Weronika Zielińska,
Joanna Ożga,
Błażej Cymerman,
Agnieszka Stępień,
Magdalena Kostkiewicz,
Katarzyna Holcman
Publication year - 2023
Publication title -
molecular imaging and radionuclide therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 7
eISSN - 2147-1959
pISSN - 2146-1414
DOI - 10.4274/mirt.galenos.2022.72593
Subject(s) - regadenoson , dipyridamole , medicine , myocardial perfusion imaging , anesthesia , nausea , blood pressure , coronary steal , cardiology , perfusion , myocardial infarction , coronary angiography
The pharmacological stress test with vasodilator agents is an alternative cardiological diagnostic tool for patients with contraindications to the classical stress test provided by physical activity during single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). The study compared the frequency of the side effects of regadenoson and dipyridamole during a SPECT MPI.